For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230918:nRSR7438Ma&default-theme=true
RNS Number : 7438M JSC Kaspi.kz 18 September 2023
WEEKLY ANNOUNCEMENT
18 September 2023
TRANSACTIONS IN OWN SECURITIES
Kaspi.kz JSC (the "Company") announces that it has purchased the following
number of its global depositary receipts representing common shares on the
London Stock Exchange and on BATS, Chi-X and Turquoise from J.P. Morgan
Securities plc ("JPMS"). Such purchase was effected pursuant to the buyback
programme of the Company as announced on 26 July 2023.
An aggregated breakdown of the trades made by JPMS as part of the buyback
programme is detailed below:
Aggregated transactions:
Days of the transaction Total number of GDRs purchased Daily weighted average purchase price of the GDRs (USD) Exchange Gross Considerations (USD)
11/09/2023 2 867 93,5383 XLON 268 174,20
11/09/2023 2 736 93,4628 BATE 255 714,10
12/09/2023 2 867 94,6396 XLON 271 331,70
12/09/2023 2 812 94,6039 BATE 266 026,25
13/09/2023 2 886 95,8632 XLON 276 661,30
13/09/2023 2 893 95,9047 BATE 277 452,30
14/09/2023 3 000 98,2940 XLON 294 882,10
14/09/2023 2 900 98,1650 BATE 284 678,40
15/09/2023 2 729 97,5381 XLON 266 181,50
15/09/2023 2 630 96,9559 BATE 254 994,00
Sum: 28 320 95,9073 2 716 095,85
A full breakdown of the individual trades made by JPMS as part of the buyback
programme is available through the link below:
http://www.rns-pdf.londonstockexchange.com/rns/7438M_1-2023-9-18.pdf
(http://www.rns-pdf.londonstockexchange.com/rns/7438M_1-2023-9-18.pdf)
This announcement does not constitute, or form part of, an offer or any
solicitation of an offer for securities in any jurisdiction.
LEI number 2549003YU6FARG8OAZ13
For further information david.ferguson@kaspi.kz +44 7427 751 275
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END POSNKFBPPBKKQCD